| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1372735A2 Conjugate of hydroxyalkyl starch and an active agent |
| 01/02/2004 | EP1372727A1 Biodegradable carrier and method for preparation thereof |
| 01/02/2004 | EP1372723A1 Semi-allogenic anti-tumour vaccine with hla haplo-identical antigen-presenting cells |
| 01/02/2004 | EP1372710A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 01/02/2004 | EP1372704A1 Monocyte-specific particulate delivery vehicle |
| 01/02/2004 | EP1372699A1 Method of improving the growth performance of an animal |
| 01/02/2004 | EP1372698A2 Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders |
| 01/02/2004 | EP1372691A2 Mucin peptide with immunoenhancing properties |
| 01/02/2004 | EP1372689A2 Use of ikk-beta inhibitors and method for discovery of said inhibitors |
| 01/02/2004 | EP1372621A1 Novel use of tyrosine kinase inhibitor |
| 01/02/2004 | EP1372528A2 Mucosal boosting following parenteral priming |
| 01/02/2004 | EP1185698A4 Automated nucleic acid compaction device |
| 01/02/2004 | EP0831921B1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 01/02/2004 | EP0746343B1 Bioartificial kidney devices coated with cells suitable for use in vivo or ex vivo |
| 01/02/2004 | EP0719343B1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 01/02/2004 | EP0663008B1 Improvements in or relating to immune response modification |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040003417 Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
| 01/01/2004 | US20040002591 50 human secreted proteins |
| 01/01/2004 | US20040002584 Proteins, polynucleotides encoding them and methods of using the same |
| 01/01/2004 | US20040002473 Pain modulation; incotinence therapy; central nervous system disorders |
| 01/01/2004 | US20040002470 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 01/01/2004 | US20040002469 Administering genetic engineered polynucleotide which codes heat shock protein; induce immunology response |
| 01/01/2004 | US20040002468 Methods of treating diabetes and other blood sugar disorders |
| 01/01/2004 | US20040002467 Antisense modulation of ADAM12 expression |
| 01/01/2004 | US20040002466 Releasing interferon from complex of interferon and nucleic acids; antitumor agents, viricide, induction immunology response |
| 01/01/2004 | US20040002465 Fungicides, parasiticides, antiprotozoa agents; binding antibiotic to nucleic acid |
| 01/01/2004 | US20040002459 Nucleic acids encoding kringle 1-5 region fragments of plasminogen |
| 01/01/2004 | US20040002454 Administering polypeptides; cardiovascular disorders |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002159 Methods for the production of chimeric adeno-associated virus (AAV) vectors, compositions of chimeric AAV vectors, and methods of use thereof |
| 01/01/2004 | US20040002157 Novel retroviral constructs |
| 01/01/2004 | US20040002153 Modulation of PTEN expression via oligomeric compounds |
| 01/01/2004 | US20040002149 Control of the ratio of LAP to LIP |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002103 Synthetic ligation reassembly in directed evolution |
| 01/01/2004 | US20040002096 Wild-type isoforms and mutations of Ikaros, and nucleic acid sequences encoding Ikaros, useful in the diagnosis and treatment of hematologic malignancy, particularly lymphoid malignancy, including leukemia, |
| 01/01/2004 | US20040002092 Hybrid and single chain meganucleases and use thereof |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 01/01/2004 | US20040001841 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 01/01/2004 | US20040001829 Methods for selectively stimulating proliferation of T cells |
| 01/01/2004 | US20040001811 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 01/01/2004 | US20040001810 Administering dosage of nucleic acids; cardiovascular disorders |
| 01/01/2004 | US20040001805 Prevention infections; gene therapy; insertion of genome; genetic engineered vaccine |
| 01/01/2004 | US20040001804 LLT uses thereof in immune system modulation |
| 12/31/2003 | WO2004001424A1 Materials and methods for inductions of immune tolerance |
| 12/31/2003 | WO2004001072A2 Method for diagnosis of colorectal tumors |
| 12/31/2003 | WO2004001068A2 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 12/31/2003 | WO2004001049A1 Methods of delivering gene therapy agents |
| 12/31/2003 | WO2004001038A1 Novel gene and protein participating in neuralization of cells or tissues and utilization thereof |
| 12/31/2003 | WO2004001032A2 Stable adenoviral vectors and methods for propagation thereof |
| 12/31/2003 | WO2004001020A2 Methods and means to promote gut absorption |
| 12/31/2003 | WO2004001004A2 Membrane associated tumor endothelium markers |
| 12/31/2003 | WO2004000883A1 Regulation of human growth hormone-releasing hormone receptor |
| 12/31/2003 | WO2004000881A1 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 12/31/2003 | WO2004000877A2 Peptides derived from the rabies virus glycoprotein g, ligands of the low-affinity receptor of neurotrophins (p75ntr) and applications thereof |
| 12/31/2003 | WO2004000875A2 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 12/31/2003 | WO2004000868A1 Oligonucleotide directed misfolding of rna |
| 12/31/2003 | WO2004000367A1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension |
| 12/31/2003 | WO2004000346A1 Preventives/remedies for cancer |
| 12/31/2003 | WO2004000287A1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof |
| 12/31/2003 | WO2004000231A2 Methods and compositions for the treament of cancer |
| 12/31/2003 | WO2004000220A2 Methods for purifying viral particles for gene therapy |
| 12/31/2003 | WO2004000164A2 Amniotic membrane mediated delivery of bioactive molecules |
| 12/31/2003 | WO2003087336A3 Estrogen receptor alpha regulated gene expression, related assays and therapeutics |
| 12/31/2003 | WO2003073918A3 Prevention of recurrence and metastasis of cancer |
| 12/31/2003 | WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/31/2003 | WO2003068939A3 Cks1 INHIBITORS |
| 12/31/2003 | WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia |
| 12/31/2003 | WO2003068165A3 Angiopoietin-1 in the treatment of disease |
| 12/31/2003 | WO2003064607A3 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
| 12/31/2003 | WO2003064471A3 Gene for peripheral arterial occlusive disease |
| 12/31/2003 | WO2003061573A3 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo |
| 12/31/2003 | WO2003056022A3 Method for producing a transgenic organism using a lentiviral expression vector such as eiav |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2003047549A3 Post-coated liposome/lipoplex for targeted drug/gene delivery and lipid linked to a delivery, targeting or stabilising moiety |
| 12/31/2003 | WO2003039344A3 Methods and compositions for correction of cardiac conduction disturbances |
| 12/31/2003 | WO2003033667A3 Use of mx gtpases in the prognosis and treatment of cancer |
| 12/31/2003 | WO2003025174A3 Regulation of human mrp1-like protein |
| 12/31/2003 | WO2003020759A9 A caspase- 8 binding protein, its preparation and use |
| 12/31/2003 | WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/31/2003 | WO2002097059B1 Chromosome-based platforms |
| 12/31/2003 | WO2002070562A3 Nuclear hormone receptor ligand binding domain |
| 12/31/2003 | WO2002070004A3 Papillomavirus vaccines |
| 12/31/2003 | WO2002067971A3 Use of endostatin in the treatment of ocular neovascularization |
| 12/31/2003 | WO2002053701A9 Epididymal lipocalin gene and uses thereof |
| 12/31/2003 | WO2002042325A3 Cyp1b1 nucleic acids and methods of use |
| 12/31/2003 | CN1464068A Human brain tissue specificity molecular marker LRRC4 |
| 12/31/2003 | CN1463986A Type-S non-virus carrier and pharmaceutical composition containing the same |
| 12/31/2003 | CN1463727A A TCM compound recipe notoginseng capsule and method for preparing the same |
| 12/31/2003 | CA2530108A1 Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof |
| 12/31/2003 | CA2499709A1 Method for diagnosis of colorectal tumors |
| 12/31/2003 | CA2491803A1 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 12/31/2003 | CA2491196A1 Materials and methods for inductions of immune tolerance |
| 12/31/2003 | CA2491038A1 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 12/31/2003 | CA2489930A1 Methods and means to promote gut absorption |
| 12/31/2003 | CA2489873A1 Ace2 activation for treatment of hypertension, heart, lung and kidney disease |
| 12/31/2003 | CA2489024A1 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 12/31/2003 | CA2488942A1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof |